Synthroid
NDC 66336-591
Product Information
Synthroid is a NDA-approved product labeled by Dispensing Solutions, Inc.. Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It is supplied as a blue product. This product entry covers the primary NDC 66336-591 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SYNTHROID;150
Code Structure Chart
Product Details
What is NDC 66336-591?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVOTHYROXINE (UNII: Q51BO43MG4)
- LEVOTHYROXINE (UNII: Q51BO43MG4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACACIA (UNII: 5C5403N26O)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POVIDONE (UNII: FZ989GH94E)
- TALC (UNII: 7SEV7J4R1U)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 966201 - SYNTHROID 150 MCG Oral Tablet
- RxCUI: 966201 - levothyroxine sodium 0.15 MG Oral Tablet [Synthroid]
- RxCUI: 966201 - Synthroid 0.15 MG Oral Tablet
- RxCUI: 966201 - Synthroid 150 MCG Oral Tablet
- RxCUI: 966225 - levothyroxine sodium 150 MCG Oral Tablet
* Please review the full disclaimer at the bottom of this page.